Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters











Database
Language
Publication year range
1.
Diagn Microbiol Infect Dis ; 108(2): 116102, 2024 Feb.
Article in English | MEDLINE | ID: mdl-37984108

ABSTRACT

Nonfermenting gram-negative (NFGN) bacteria were isolated from cystic fibrosis (CF) patients and subjected to susceptibility testing and whole-genome sequencing. Among 170 enrolled CF patients, 112 (65.9%) were colonized with at least 1 key NFGN species. The species-specific infection rate was highest for Pseudomonas aeruginosa (40.6%) followed by Stenotrophomonas maltophilia (14.1%), Achromobacter spp. (9.4%), and Burkholderia cepacia complex (Bcc, 8.2%) demonstrating a significant age-dependent increase for P. aeruginosa and Achromobacter spp., but not for S. maltophilia or Bcc. P. aeruginosa sequence types (STs) related to high-risk epidemic and global CF clones were carried by 12 (7.1%) and 13 (7.6%) patients, respectively. In total, 47% NFGN isolates, predominantly P. aeruginosa, harbored at least 1 plasmid-borne resistance gene; 5 ST235 isolates carried blaVIM2. Pathogenicity island-borne virulence genes were harbored by 9% NFGN isolates. These findings in conjunction with frequent early colonization by Bcc raised serious concerns regarding infection control in Russian CF centers.


Subject(s)
Cystic Fibrosis , Stenotrophomonas maltophilia , Humans , Anti-Bacterial Agents/pharmacology , Cystic Fibrosis/complications , Cystic Fibrosis/microbiology , Drug Resistance, Bacterial , Gram-Negative Bacteria , Stenotrophomonas maltophilia/genetics , Pseudomonas aeruginosa/genetics
2.
Heliyon ; 9(6): e16618, 2023 Jun.
Article in English | MEDLINE | ID: mdl-37292356

ABSTRACT

Burkholderia cepacia complex (Bcc) bacteria are considered to be very dangerous players in cystic fibrosis (CF) pathogenesis and are a criterion for negative prognosis in CF cases. In this report, a pediatric case of paranasal sinusitis caused by Burkholderia cenocepacia in a CF patient is described. This is an unusual case, since the paranasal sinuses were the only colonization locus of B. cenocepacia in this patient for 5 years (2015-2020). The lungs remained microbiologically clear with no clinical or radiological signs of pulmonary function decrease during this time period. The paranasal sinuses were sanitized by endoscopic sinus surgery on the left side (2020). Although having no local or systemic antibiotic treatment from the time of surgery to 2022, no B. cenocepacia were detected in the samples. The case shows the possibility of a prolonged remission of Bcc-associated paranasal sinusitis in the absence of systemic antibiotic therapy.

3.
Diagn Microbiol Infect Dis ; 102(3): 115596, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34902620

ABSTRACT

The dissemination of multiple-drug resistant high virulent strains of P. aeruginosa in patients with cystic fibrosis is of concern worldwide. Herein, we describe genomic characteristics of ST235 isolates recovered from cystic fibrosis patients in Russia. Successful core-genome background and acquired resistance determinants provide spreading of high-risk clones in cystic fibrosis populations.


Subject(s)
Cystic Fibrosis , Pseudomonas Infections , Anti-Bacterial Agents/pharmacology , Cystic Fibrosis/complications , Drug Resistance, Multiple, Bacterial/genetics , Humans , Pseudomonas Infections/epidemiology , Pseudomonas aeruginosa/genetics , Virulence/genetics
4.
Int J Antimicrob Agents ; 55(4): 105899, 2020 Apr.
Article in English | MEDLINE | ID: mdl-31931151

ABSTRACT

Pseudomonas aeruginosa is a serious opportunistic pathogen demonstrating a high level of resistance to many groups of antibiotics, including carbapenems. This study aimed to characterise the molecular epidemiology and prevalence of mobile genetic elements associated with resistance to carbapenems among P. aeruginosa (CRPA) clinical isolates. Among 145 carbapenem-resistant P. aeruginosa isolates, 34 different sequence types (STs) were detected; the six most common STs were ST654 (24%), ST235 (24%), ST111 (8%), ST446 (6%), ST357 (5%) and ST2592 (a novel single-locus variant of ST357) (4%). A carbapenemase gene was found in 94 isolates (64.8%). The blaVIM-2 gene was harboured by 64 isolates (44.1%) restricted to ST111, ST235 and ST654, and the blaGES-type and blaOXA-10 group genes were each detected in 15 isolates (10.3%); none of other tested carbapenemase genes, including blaIMP, blaNDM and blaGIM, were detected. Among the blaVIM-2-positive isolates, five types of blaVIM-2-containing integrons were discovered, including In56, In559, In59-like, In59 and In249. The oprD gene was disrupted by an insertion sequence (IS) in 15.9% of isolates. Overall, five types of IS elements were found (ISPsme1, ISPa1328, ISPa26, ISPst2 and ISPa195). Observed rearrangements within variable regions of blaVIM-2-carrying integrons in conjunction with the discovery of a novel type of oprD-disrupting IS element illustrate the ongoing evolution of CRPA a, which warrants further investigation.


Subject(s)
Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , Carbapenems/pharmacology , Integrons/genetics , Porins/genetics , Pseudomonas aeruginosa/drug effects , beta-Lactamases/genetics , Drug Resistance, Multiple, Bacterial/genetics , Genetic Variation/genetics , Humans , Microbial Sensitivity Tests , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/genetics , Pseudomonas aeruginosa/isolation & purification , Russia
5.
J Glob Antimicrob Resist ; 17: 309-311, 2019 06.
Article in English | MEDLINE | ID: mdl-30684654

ABSTRACT

OBJECTIVES: Alteration of the porin-encoding gene oprD by insertion sequences (ISs) is one mechanism conferring carbapenem resistance in Pseudomonas aeruginosa. Here we describe a carbapenem-resistant clinical P. aeruginosa isolate 36-989 harbouring a novel IS (ISPa195) in oprD. METHODS: Minimum inhibitory concentrations (MICs) of antimicrobial agents were determined by the broth microdilution method. Carbapenemase activity was assessed using a MALDI-TOF/MS-based assay of meropenem hydrolysis. Efflux-dependent carbapenem resistance was evaluated using an assay with carbonyl cyanide 3-chlorophenylhydrazone (CCCP). The oprD gene and IS sequence were analysed by the Sanger method. Whole-genome sequencing was performed on an Illumina HiSeq 2500 platform. RESULTS: Antimicrobial susceptibility testing demonstrated that P. aeruginosa 36-989 was resistant to imipenem (MIC=32mg/L) and meropenem (MIC=16mg/L). No carbapenemase activity was detected, however an efflux-mediated component of carbapenem resistance was revealed. A new IS element (ISPa195) was found in the oprD gene of P. aeruginosa 36-989. ISPa195 was 1190bp in length, belonging to the IS3 family, and contained two open reading frames that overlapped through a ribosomal slippage to translate the full-size transposase enzyme. There was an IS-associated 284-bp deletion in the oprD gene; no direct repeats at flanking regions of the IS were detected. CONCLUSION: The absence of direct repeats at flanking regions in combination with the IS-associated deletion distinguished ISPa195 from other ISs previously detected in oprD. Carbapenem resistance in P. aeruginosa 36-989 was conferred by a combination of oprD alteration and carbapenem efflux.


Subject(s)
DNA Transposable Elements/genetics , Drug Resistance, Multiple, Bacterial/genetics , Porins/genetics , Pseudomonas aeruginosa/genetics , Sequence Deletion , Anti-Bacterial Agents/pharmacology , Bacterial Proteins , Carbapenems/pharmacology , Gene Components , Humans , Imipenem/pharmacology , Meropenem/metabolism , Microbial Sensitivity Tests , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/drug effects , beta-Lactamases
SELECTION OF CITATIONS
SEARCH DETAIL